NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC MOU WITH DROMNI INTELLIGENCE TO DEVELOP AI-POWERED AUTONOMOUS ROBOTICS SOLUTIONS FOR U.S. AGRICULTURE, ENERGY AND DATA CENTER MARKETS
Partnership Focused on UGV Deployment, Smart Infrastructure Automation and AI-Driven Robotics Commercialization…
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
– BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and…